Trials / Unknown
UnknownNCT03257345
VEST: The UK Vedolizumab Real Life Experience Study in Inflammatory Bowel Disease
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 360 (estimated)
- Sponsor
- University Hospital Southampton NHS Foundation Trust · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Vedolizumab has been approved for the treatment of both ulcerative colitis and Crohn's disease. The aim of this study is to capture the early real life UK experience of vedolizumab including the outcomes of treatment, describing the patient population treated, drug persistence, IBD control PROM, durable remission, tolerance and safety.
Conditions
Timeline
- Start date
- 2017-02-03
- Primary completion
- 2019-09-30
- Completion
- 2019-12-31
- First posted
- 2017-08-22
- Last updated
- 2018-09-21
Locations
22 sites across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT03257345. Inclusion in this directory is not an endorsement.